Lafayette resident and Stage IV cancer patient Keith Hollingsworth is lucky to be here. Others in the near future may not be ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

There’s no cure for Alzheimer’s yet, but scientists may be getting closer using an unlikely tool … cancer drugs. Researchers ...

Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early detection and prevention.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

With so few Alzheimer's drugs available, repurposing medications approved for other conditions could be the key to tackling ...

New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment ...

Targeted Drug Therapy for Breast Cancer Targeted drug therapy uses medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and live longer. Targeted drugs ...

Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, doxorubicin, methotrexate, and leucovorin.

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.

By Colin Kellaher Gilead Sciences and Kymera Therapeutics have inked an exclusive cancer-drug option and licensing agreement potentially worth hundreds of million of dollars to Kymera.